Metabolism and Anticancer Activity of the Curcumin Analogue, Dimethoxycurcumin
- 15 February 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 13 (4), 1269-1277
- https://doi.org/10.1158/1078-0432.ccr-06-1839
Abstract
Purpose: The plant-derived compound curcumin has shown promising abilities as a cancer chemoprevention and chemotherapy agent in vitro and in vivo but exhibits poor bioavailability. Therefore, there is a need to investigate modified curcumin congeners for improved anticancer activity and pharmacokinetic properties. Experimental Design: The synthetic curcumin analogue dimethoxycurcumin was compared with curcumin for ability to inhibit proliferation and apoptosis of human HCT116 colon cancer cells in vitro by estimating the GI50 and LC50 values and detecting the extent of apoptosis by flow cytometry analysis of the cell cycle. Metabolic stability and/or identification of metabolites were evaluated by recently developed mass spectrometric approaches after incubation with mouse and human liver microsomes and cancer cells in vitro. Additionally, circulating levels of dimethoxycurcumin and curcumin were determined in mice following i.p. administration. Results: Dimethoxycurcumin is significantly more potent than curcumin in inhibiting proliferation and inducing apoptosis in HCT116 cells treated for 48 h. Nearly 100% of curcumin but in vivo but dimethoxycurcumin was more stable. Conclusions: Compared with curcumin, dimethoxycurcumin is (a) more stable in cultured cells, (b) more potent in the ability to kill cancer cells by apoptosis, (c) less extensively metabolized in microsomal systems, and (d) more stable in vivo. It is likely that the differential extent of apoptosis induced by curcumin and dimethoxycurcumin in vitro is associated with the metabolite profiling and/or the extent of stability.Keywords
This publication has 34 references indexed in Scilit:
- Inhibition of telomerase activity and induction of apoptosis by curcumin in K-562 cellsMutation Research, 2006
- Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcuminJournal of Pharmaceutical and Biomedical Analysis, 2006
- Multiple biological activities of curcumin: A short reviewLife Sciences, 2006
- Curcumin Inhibits Phorbol Ester-Induced Up-Regulation of Cyclooxygenase-2 and Matrix Metalloproteinase-9 by Blocking ERK1/2 Phosphorylation and NF-κB Transcriptional Activity in MCF10A Human Breast Epithelial CellsAntioxidants and Redox Signaling, 2005
- Curcumin: The story so farEuropean Journal Of Cancer, 2005
- Curcumin as a DNA Topoisomerase II PoisonJournal of Enzyme Inhibition and Medicinal Chemistry, 2003
- Differential susceptibility to 9-nitrocamptothecin (9-NC)-induced apoptosis in clones derived from a human ovarian cancer cell line: possible implications in the treatment of ovarian cancer patients with 9-NCAnti-Cancer Drugs, 2003
- Inhibition of cell survival signal protein kinase B/Akt by curcumin in human prostate cancer cellsJournal of Cellular Biochemistry, 2003
- Camptothecin derivatives induce regression of human ovarian carcinomas grown in nude mice and distinguish between non‐tumorigenic and tumorigenic cells in vitroInternational Journal of Cancer, 1993
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI Journal of the National Cancer Institute, 1990